Connect with us

Technology

SterlingBio Secures Global Distribution and Operation of SureClinical’s Validated Clinical Trial Applications, Platform, and Compliant Cloud

Published

on

SterlingBio Aims to Democratize Clinical Trial Application Affordability, Accessibility, and Availability to Reduce Drug Development Costs Globally

REDWOOD SHORES, Calif., May 31, 2024 /PRNewswire-PRWeb/ — SterlingBio, a leading US woman-owned Contract Research Organization (CRO), is thrilled to announce that it has secured exclusive global distribution rights for SureClinical’s cutting-edge eClinical apps, platform, and cloud, including the management of all existing SureClinical cloud operations and customer instances. This strategic transaction represents a significant step forward in the democratization of clinical trial data and solutions, reinforcing SterlingBio’s commitment to helping organizations, patients and agencies achieve better results in healthcare through innovative and accessible clinical research applications, services and clinical intelligence.

“Unlike a handful of Big CROs that control access and prices to clinical software and services, SterlingBio aims to provide a more affordable alternative. With SterlingBio, clients can receive Smart CRO services and their apps for free,” said Catherine Schmidt, CEO of SterlingBio.

In an unprecedented move to support current and future clients, SterlingBio will offer SureClinical applications for free with select SterlingBio managed application service agreements. This initiative underscores SterlingBio’s commitment to providing exceptional value and support to its clients, ensuring they have access to the best clinical tools and services at an affordable price.

“We are excited to secure the SureClinical eClinical ecosystem and cloud operations for our clients,” said Catherine Schmidt, CEO of SterlingBio. “Unlike a handful of Big CROs that control access and prices to clinical software and services, SterlingBio aims to provide a more affordable alternative. With SterlingBio, clients can receive Smart CRO services and their apps for free.”

SterlingBio’s Validated Clinical Apps and Cloud
SterlingBio’s SureClinical applications and platform will continue to be available to existing and new clients through the SureClinical Compliant Cloud, which maintains multiple FDA, EU, HIPAA, and ISO certifications, independently compliance validated by USDM. In order to assure a seamless transition for existing SureClinical client instances and subscriptions, SterlingBio will continue to provide support through the end of existing subscription agreements at no additional cost. Alternatively, existing customers can transition to a new Managed Application Services agreement under SterlingBio, with CRO services, support, administration, and management. Additional information on SterlingBio managed services is available at http://www.SterlingBio.com, along with an FAQ on the SureClinical / SterlingBio transition.

SureClinical applications and platform are renowned for advanced features that streamline and automate clinical trial processes, improve data quality, and enhance regulatory compliance. By offering the SureClinical eClinical ecosystem with SterlingBio’s existing Managed Application Services, SterlingBio aims to provide biopharma companies with an affordable, comprehensive solution that simplifies the complexities of clinical trial management, democratizing access to clinical solutions for almost any clinical researcher or sponsor regardless of size.

Initially released in 2014, SureClinical’s applications were built on a flexible framework that supports interoperability with virtually any web application. SureClinical’s apps and platform support multiple application standards, such as the OASIS eTMF standard. As an early proponent of AI and machine learning, SureClinical’s apps were built on web standards including RDF/XML, a technology used in AI knowledge graphs for automated data classification, search, and analysis. SureClinical applications have been used by thousands of users on hundreds of clinical trials globally. SureClinical applications and platform have been independently compliance validated by USDM for FDA, EU, ISO, GDPR, SOC, HIPAA, and other compliance standards and have passed multiple regulatory agency audits and inspections.

Further demonstrating its commitment and mission to democratize clinical applications accessibility, affordability, and availability, SterlingBio will be separately announcing its sponsorship for a community-driven open-source initiative to connect any eClinical app, data, or cloud for free use by anyone in clinical research and development.
For more information about SterlingBio’s new services and the benefits of SureClinical’s clinical software, please visit http://www.SterlingBio.com or contact SterlingBio PR at info@sterlingbio.com, or by phone at 1-650-206-2054.

About SterlingBio
SterlingBio, founded in 2001, is a woman-owned Contract Research Organization (CRO) based in the USA. SterlingBio, the ‘We Care CRO™,’ is dedicated to providing top-tier clinical research and development services to the biopharma industry. With a focus on managed application services, consulting, technical services and staffing, SterlingBio is committed to helping organizations, patients and agencies achieve better results in healthcare. 

For media inquiries, please contact: 
SterlingBio PR
info@SterlingBio.com
1-650-206-2054

Media Contact

SterlingBio PR, SterlingBio, 1-650-206-2054, info@sterlingbio.com, https://www.sterlingbio.com

View original content to download multimedia:https://www.prweb.com/releases/sterlingbio-secures-global-distribution-and-operation-of-sureclinicals-validated-clinical-trial-applications-platform-and-compliant-cloud-302161004.html

SOURCE SterlingBio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MagFone Christmas & New Year Sale: Unbeatable Discounts for the Holiday Season

Published

on

By

The festive season is upon us, and MagFone is here to make your holidays even brighter with an exclusive Christmas & New Year sale! From incredible discounts on best-selling products to special deals on new products, MagFone is the ultimate destination for holiday shopping. From December 18, 2024 to January 6, 2025, this sale offers up to 80% off discount for everyone. Let’s dive into the details of the most awaited sale of the year.

HONGKONG, Dec. 21, 2024 /PRNewswire-PRWeb/ — What Can You Get from MagFone Christmas & New Year Sale?

New arrival – Location Changer is only $1.99 to everyone in this MagFone Christmas & New Year Grand sales. Moreover, everyone can enjoy up to 80% OFF.

1. Best-Selling Products at Up to 70% OFF

Resolving various iOS system issues or unlocking locked Apple devices like iPhone and iPad by yourself at home with MagFone’s flagship products, now available at unbeatable prices. Best-selling products such as iPhone Unlocker, Activation Unlocker, and iOS System Recovery are up for grabs with discounts of up to 70% off. Don’t miss out on this chance to get MagFone’s best-selling products at jaw-dropping prices.

MagFone iPhone Unlocker at $20.95/month and $41.95/lifetime.MagFone Activation Unlocker at $20.95/month and $41.95/lifetime.MagFone iOS System Recovery at $17.95/month and $48.95/lifetime.

2. New Arrival to Get with Only $1.99

Whether you want to change your location on your mobile device or simulate GPS movement in various games, MagFone’s new product – Location Changer – is perfect for you. Designed for both iOS and Android users, this tool comes equipped with advanced location changing features, flexible movement speed, and customizable route. With only $1.99, it is a must-have for this Christmas sale if you have the demand to change your device location.

3. 4-in-1 Bundle to Maximize Your Savings

MagFone values all loyal customers and offers exclusive pers during the Christmas & New Year sale. A super 4-in-in bundle is at reduced prices, which enables you to get all products from MagFone with an 80% off discount. This bundle includes all the tools you need, whether you’re looking to resolve various system problems and unlocking issues or change iPhone and Android device’s location. Don’t miss this chance to get all MagFone products at unbeatable prices.

MagFone Christmas & New Year Sale is a limited-time event, running from December 18, 2024 to January 6, 2025. With discount this good, products are expected to get at the lowest price this year. Don’t wait until the last minute—start shopping now to get MagFone products at the best deals.

About MagFone:

MagFone is redefining tech innovation with state-of-the-art technology and intuitive design. Whether their flagship products like iPhone Unlocker or newly-released tools like Location Changer, MagFone products are built for performance and flexibility.

YouTube: https://www.youtube.com/@magfone

Facebook: https://www.facebook.com/magfone/

X: https://x.com/magfone

Media Contact

Olivia Wood, MagFone, 86 19186985874, support@magfone.com, https://www.magfone.com/

View original content to download multimedia:https://www.prweb.com/releases/magfone-christmas–new-year-sale-unbeatable-discounts-for-the-holiday-season-302337015.html

SOURCE MagFone

Continue Reading

Technology

Dr. Ashley Milhizer Sees 300% Growth in 2024 at Real Results Medical & Aesthetics

Published

on

By

After nearly two years in business, Dr. Ashley Milhizer’s Tempe-based center for naturopathic medicine and aesthetics has experienced the type of growth that rival industry titans. Real Results Medical & Aesthetics – soon to be opening a second location in Scottsdale in early 2025 – has seen an impressive 300% growth since opening their doors in March 2023.

TEMPE, Ariz., Dec. 21, 2024 /PRNewswire-PRWeb/ — After nearly two years in business, Dr. Ashley Milhizer’s Tempe-based center for naturopathic medicine and aesthetics has experienced the type of growth that rival industry titans. Real Results Medical & Aesthetics – soon to be opening a second location in Scottsdale in early 2025 – has seen an impressive 300% growth since opening their doors in March 2023.

Aside from patient referrals and cutting-edge technology, Milhizer credits social media as one of the biggest avenues for growth. “Between TikTok and Instagram we’ve amassed over 25,000 followers and that accounts for about 70% of our new business.”

Aside from patient referrals and cutting-edge technology, Milhizer credits social media as one of the biggest avenues for growth. “Between TikTok and Instagram we’ve amassed over 25,000 followers and that accounts for about 70% of our new business,” said Dr. Ashley Milhizer, Founder of Real Results Medical & Aesthetics.

On both platforms, Dr. Milhizer shares educational videos and insights into various medical & aesthetic procedures. Her engaging content not only highlights the quality of care she provides but also educates her audience on the latest trends and treatments in the field.

Originally from Michigan, and a graduate of UC Davis and the Southwest College of Naturopathic Medicine & Health Sciences, it was Dr. Milhizer’s personal experience in seeing how natural remedies can significantly impact the body that inspired her to get into the field.

“While I was in school, a friend of mine was diagnosed with stage 3 cancer and was given up to 18 months to live and I became determined to research every kind of remedy that could potentially help,” said Dr. Milhizer. “From a healthy diet, supplements and a host of other naturopathic strategies, we tried everything we could find and two months later he was in remission, and he’s still alive today.”

The power of naturopathic remedies, following an early career path in sports medicine – which enabled her to work with some of the state’s top professional athletes – is what led her to forming Real Results Medical & Aesthetics. The company’s broad depth of services is also what allowed her to expand her reach of clientele beyond athletes to everyone from the Valley’s elite CEOs and stay at home Moms to patients ranging from their early 20s to upper 80s.

The naturopathic services offered at Real Results Medical & Aesthetics include hormone optimization, peptide therapy, IV therapy, natural pain relief, weight loss, food allergy testing and overall diagnostic testing. While the aesthetics side of the business offers services such as hair restoration, skin resurfacing, botox, fillers, microneedling, RF Plasma skin resurfacing, laser treatments, vein removal and body contouring.

For more information on Real Results Medical & Aesthetics, visit www.realresultsmedical.com or call/text 480.245.5636. For ongoing news, updates and service offerings, follow Dr. Milhizer on Facebook, Instagram and LinkedIn.

Media Contact

Kendra Riley, Real Results Medical & Aesthetics, 1 4802206051, kendra@dawningpr.com 

View original content to download multimedia:https://www.prweb.com/releases/dr-ashley-milhizer-sees-300-growth-in-2024-at-real-results-medical–aesthetics-302337009.html

SOURCE Real Results Medical & Aesthetics

Continue Reading

Technology

ICEYE expands its Earth Observation capabilities with launch of two SAR satellites for mid-inclination orbit on the Bandwagon-2 mission with SpaceX

Published

on

By

Mid-inclination orbit provides more SAR-imaging opportunities at middle latitudes of the globe for ICEYE customers.

HELSINKI, Finland, Dec. 21, 2024 /PRNewswire/ — ICEYE, the global leader in SAR satellite operations for Earth Observation and persistent monitoring, announced today that it has launched two new satellites to its constellation of SAR satellites. Both satellites expand the availability of ICEYE’s latest imaging technology to deliver additional 25 cm imaging capacity. The satellites were integrated via Exolaunch and launched as part of the Bandwagon-2 rideshare mission with SpaceX from Vandenberg Space Force Base in California, USA. Both satellites have established communication, and early routine operations are underway. With today’s launch, ICEYE has successfully launched 40 satellites into orbit since 2018, with nine satellites launched in 2024 alone.

The new SAR satellites were launched into mid-inclination orbits; compared to a polar orbit, these mid-inclination orbits provide more than twice the collection opportunities at middle latitudes of the globe. ICEYE customers have many areas of interest in these middle latitudes (+/- 45 degrees), and these customers will benefit from increased persistence over these regions. Customers with imaging interests outside these middle latitudes will continue to benefit from the frequent revisit enabled by ICEYE’s dozens of satellites in polar orbits. ICEYE’s unique mix of mid-inclination and polar orbits provides its customers with deep revisit capabilities for targets all around the globe. The new satellites will serve ICEYE’s commercial missions as part of the world’s largest SAR satellite constellation owned and operated by ICEYE.

Rafal Modrzewski, CEO and Co-founder of ICEYE said: “This launch marks another significant milestone in ICEYE’s ability to provide our customers with a rich diversity of collection opportunities. We bolster our industry-leading SAR constellation and expand our customers’ collection opportunities in the areas most important to them.”

Today’s launch is another step forward in ICEYE’s steady drumbeat of innovative breakthroughs in Earth Observation. This year alone, ICEYE has, for example, introduced Dwell Precise, a new 25 cm imaging mode that offers its customers the highest-fidelity 25cm imaging capability, and adds advanced capability to ICEYE’s line of Dwell products; launched an API that allows customers to directly task its SAR satellite constellation; and launched ICEYE Ocean Vision to provide actionable intelligence for maritime domain awareness.

About ICEYE

ICEYE delivers unparalleled persistent monitoring capabilities to detect and respond to changes in any location on Earth, faster and more accurately than ever before.

Owning the world’s largest synthetic aperture radar (SAR) satellite constellation, ICEYE provides objective, near real-time insights, ensuring that customers have unmatched access to actionable high-quality data, day or night, even in challenging environmental conditions. As a trusted partner to governments and commercial industries, ICEYE delivers intelligence in sectors such as insurance, natural catastrophe response and recovery, security, maritime monitoring, and finance, enabling decision-making that contributes to community resilience and sustainable development.

ICEYE operates internationally with offices in Finland, Poland, Spain, the UK, Australia, Japan, UAE, Greece, and the US.  We have more than 700 employees, inspired by the shared vision of improving life on Earth by becoming the global source of truth in Earth Observation.

Media contact: press@iceye.com

Visit www.iceye.com and follow ICEYE on LinkedIn and X for the latest updates and insights.

View original content to download multimedia:https://www.prnewswire.com/news-releases/iceye-expands-its-earth-observation-capabilities-with-launch-of-two-sar-satellites-for-mid-inclination-orbit-on-the-bandwagon-2-mission-with-spacex-302337876.html

SOURCE ICEYE

Continue Reading

Trending